Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of LCK mRNA | decreases expression | 12419474
|
C072876 |
A 771726 |
A 771726 inhibits the reaction [TNF protein results in increased activity of LCK protein] | decreases reaction|increases activity | 9973483
|
C014949 |
acetylhydrazine |
acetylhydrazine results in decreased expression of LCK mRNA | decreases expression | 15282401
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of LCK mRNA | affects expression | 17331233
|
C472777 |
bisperoxovanadium |
LCK protein affects the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA] | affects reaction|increases expression | 12493747
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of LCK mRNA | increases expression | 18180321
|
C471992 |
bosutinib |
bosutinib results in decreased activity of LCK protein | decreases activity | 17114238
|
C074702 |
chromium hexavalent ion |
LCK protein affects the reaction [chromium hexavalent ion results in increased expression of IL6 mRNA] | affects reaction|increases expression | 17078813
|
C074702 |
chromium hexavalent ion |
LCK protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of STAT3 protein alternative form] | affects reaction|increases phosphorylation | 17078813
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LCK mRNA] | decreases reaction|increases expression | 11007951
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of LCK mRNA | affects cotreatment|decreases expression | 17404688
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of LCK mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of LCK mRNA | increases expression | 17942748
|
C029424 |
hydrazine |
hydrazine results in decreased expression of LCK mRNA | decreases expression | 15282401
|
C097613 |
imatinib |
imatinib results in decreased phosphorylation of LCK protein | decreases phosphorylation | 15100154
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of LCK mRNA | decreases expression | 16807920
|
D008727 |
Methotrexate |
LCK protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of LCK mRNA | decreases expression | 17426115
|
D011192 |
Potassium Dichromate |
LCK protein affects the reaction [Potassium Dichromate results in increased expression of IL6 mRNA] | affects reaction|increases expression | 17078813
|
D011192 |
Potassium Dichromate |
LCK protein affects the reaction [Potassium Dichromate results in increased phosphorylation of STAT3 protein alternative form] | affects reaction|increases phosphorylation | 17078813
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of LCK mRNA | affects cotreatment|decreases expression | 17404688
|
C021747 |
sodium selenate |
sodium selenate results in increased expression of LCK mRNA | increases expression | 16444006
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of LCK mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LCK mRNA] | decreases reaction|increases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LCK mRNA | increases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LCK mRNA | increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.44 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
8.23 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.23 | 15322242 14514962 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
5.15 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
6.11 | 18322153 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.84 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.01 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.13 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.13 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.54 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.54 | 16835633 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.03 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.36 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.60 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.07 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.43 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.43 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
5.22 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.76 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.23 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.15 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.71 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.71 | 17261762 12948864 17018787 16675129 14630087 17289903 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
3.71 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
3.71 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
3.71 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.71 | 15565566 19103187 19189210 19288272 20135344 18425577 15668708 19289846 19142967 19059307 16202921 17242785 19115204 19066611 19011961 16818667 17893378 18984771 19189212 20065188 19221464 17440819 18815881 20005174 18351453 19200415 19155303 21152245 18855134 18821012 11161223 19244106 19084267 20859285 21138602 18997820 19410462 16873071 20544844 16273361 18629630 19487384 17049068 17261762 20390343 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.71 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.40 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
2.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
2.93 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.88 | 17123778 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.52 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.70 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.47 | 15861022 16105132 17110522 17681005 17333356 16919318 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.47 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.06 | 15668235 15340226 16354765 8697196 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
3.99 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.99 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.99 | 20055451 10048152 15322242 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.14 | 19747007 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.25 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Potassium Dichromate |
4.20 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.02 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.52 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.52 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.38 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.51 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D004487 |
Edema |
|
imatinib |
10.98 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.98 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.98 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.80 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.70 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
14.70 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.70 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.15 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.15 | 19155303 16202921 20544844 17893378 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.60 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.60 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.93 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
12.45 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.45 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
12.45 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.17 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.42 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
11.47 | 17453242 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
11.47 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.84 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.04 | 16518429 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.27 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.47 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.90 | 16221962 19176532 19772884 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.90 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 8697196 16959395 15340226 16354765 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.08 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.87 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.70 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.29 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.36 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.41 | 17937319 |
MESH:D007249 |
Inflammation |
|
Progesterone |
7.97 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.97 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.97 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.90 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.90 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.90 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.23 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.36 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Potassium Dichromate |
6.36 | 19665454 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.08 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
7.08 | 18625569 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.00 | 9562676 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
4.69 | 15748426 15107311 17301526 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
5.00 | 17236224 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.08 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.64 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.60 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
6.60 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.60 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.60 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.60 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.09 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.09 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.09 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.04 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
chromium hexavalent ion |
4.55 | 16775837 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
4.92 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.91 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
chromium hexavalent ion |
3.51 | 16876463 16570259 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.51 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.87 | 17352296 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.65 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.56 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.56 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.56 | 19196722 11731420 16827153 14580682 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.29 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.29 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.87 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.07 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.14 | 16166281 16966607 18303189 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.17 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.40 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.10 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.97 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.97 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
6.12 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
6.12 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.48 | 19410462 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
1.90 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
10.83 | 17614352 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
10.83 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
15.74 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.74 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.74 | 14600291 |
MESH:D009669 |
Nose Neoplasms |
|
chromium hexavalent ion |
5.01 | 16876463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.79 | 20558911 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.63 | 15867366 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.88 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.76 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.76 | 17393432 16525653 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.58 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.40 | 11550810 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.78 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.42 | 12476293 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
9.15 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.15 | 11896295 11118676 11399792 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.21 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.59 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.59 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.59 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.20 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.40 | 17410198 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.68 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.99 | 17365031 15814490 17322281 17975199 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.60 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.33 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.82 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.99 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.21 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.21 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.51 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.51 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
3.20 | 15786421 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.88 | 16684133 16045194 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.93 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.52 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.06 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
4.34 | 16940797 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.31 | 16712894 17572228 8653321 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.90 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.19 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.44 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |